192 related articles for article (PubMed ID: 15784554)
1. Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody.
Moe GR; Dave A; Granoff DM
Infect Immun; 2005 Apr; 73(4):2123-8. PubMed ID: 15784554
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies.
Moe GR; Dave A; Granoff DM
Mol Immunol; 2006 Mar; 43(9):1424-31. PubMed ID: 16140379
[TBL] [Abstract][Full Text] [Related]
3. Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C.
Moe GR; Bhandari TS; Flitter BA
J Immunol; 2009 May; 182(10):6610-7. PubMed ID: 19414816
[TBL] [Abstract][Full Text] [Related]
4. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.
Coquillat D; Bruge J; Danve B; Latour M; Hurpin C; Schulz D; Durbec P; Rougon G
Infect Immun; 2001 Nov; 69(11):7130-9. PubMed ID: 11598089
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.
Granoff DM; Bartoloni A; Ricci S; Gallo E; Rosa D; Ravenscroft N; Guarnieri V; Seid RC; Shan A; Usinger WR; Tan S; McHugh YE; Moe GR
J Immunol; 1998 May; 160(10):5028-36. PubMed ID: 9590252
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hurpin CM; Carosella ED; Cazenave PA
Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
[TBL] [Abstract][Full Text] [Related]
7. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
Pon RA; Lussier M; Yang QL; Jennings HJ
J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
[TBL] [Abstract][Full Text] [Related]
8. Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide.
Beninati C; Arseni S; Mancuso G; Magliani W; Conti S; Midiri A; Biondo C; Polonelli L; Teti G
J Immunol; 2004 Feb; 172(4):2461-8. PubMed ID: 14764718
[TBL] [Abstract][Full Text] [Related]
9. N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis.
Jennings HJ; Gamian A; Ashton FE
J Exp Med; 1987 Apr; 165(4):1207-11. PubMed ID: 2435835
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
11. Structure of a protective epitope reveals the importance of acetylation of
Henriques P; Dello Iacono L; Gimeno A; Biolchi A; Romano MR; Arda A; Bernardes GJL; Jimenez-Barbero J; Berti F; Rappuoli R; Adamo R
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29795-29802. PubMed ID: 33158970
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide.
Ashton FE; Ryan JA; Michon F; Jennings HJ
Microb Pathog; 1989 Jun; 6(6):455-8. PubMed ID: 2505013
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.
Bartoloni A; Norelli F; Ceccarini C; Rappuoli R; Costantino P
Vaccine; 1995 Apr; 13(5):463-70. PubMed ID: 7543714
[TBL] [Abstract][Full Text] [Related]
14. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
Jennings HJ; Roy R; Gamian A
J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.
Park IH; Youn JH; Choi IH; Nahm MH; Kim SJ; Shin JS
Infect Immun; 2005 Oct; 73(10):6399-406. PubMed ID: 16177311
[TBL] [Abstract][Full Text] [Related]
16. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope.
Michon F; Huang CH; Farley EK; Hronowski L; Di J; Fusco PC
Dev Biol (Basel); 2000; 103():151-60. PubMed ID: 11214233
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
Park IH; Lin J; Choi JE; Shin JS
Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.
Devi SJ; Zollinger WD; Snoy PJ; Tai JY; Costantini P; Norelli F; Rappuoli R; Frasch CE
Infect Immun; 1997 Mar; 65(3):1045-52. PubMed ID: 9038314
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide.
Menéndez T; Santiago-Vispo NF; Cruz-Leal Y; Coizeau E; Garay H; Reyes O; Batista Y; Cobas K; Carmenate T; Chinea G; Guillén G
Int J Med Microbiol; 2011 Jan; 301(1):16-25. PubMed ID: 20708963
[TBL] [Abstract][Full Text] [Related]
20. Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.
Berry DS; Lynn F; Lee CH; Frasch CE; Bash MC
Infect Immun; 2002 Jul; 70(7):3707-13. PubMed ID: 12065513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
